title: HPV vaccination in women aged 24-45 years.
authors.forename: Diane
authors.initials: D
authors.lastname: Solomon
authors.forename: Phil
authors.initials: P
authors.lastname: Castle
authors.forename: Allan
authors.initials: A
authors.lastname: Hildesheim
authors.forename: Hormuzd A
authors.initials: HA
authors.lastname: Katki
authors.forename: Mark
authors.initials: M
authors.lastname: Schiffman
authors.forename: Sholom
authors.initials: S
authors.lastname: Wacholder
mesh_terms: D000328:Adult; D005260:Female; D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D006801:Humans; D008875:Middle Aged; D053918:Papillomavirus Vaccines / Q000276:immunology*; D011634:Public Health; D016032:Randomized Controlled Trials as Topic; D012107:Research Design; D014611:Vaccination; D002578:Uterine Cervical Dysplasia / Q000453:epidemiology / Q000517:prevention & control / Q000821:virology
chemical_list: D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D053918:Papillomavirus Vaccines